This #bloodcancerawareness month, we’re honored to introduce Karen, a multiple myeloma survivor who reflects on her cancer journey and the critical role of minimal residual disease (MRD) testing.

Adaptive is committed to recognizing scientists pursuing exciting research in immunology. Hear from our latest immunoSEQ® YIA and WISE award winners in our latest blog post. adaptivebio.tech/zv8 For Research Use Only. Not for use in diagnostic procedures.

Attending the 7th @CAR_TCell Summit in Boston, MA next week? Join Sr. Director @ErikYusko for his Discovery Track presentation on, “Adaptive’s TCR Discovery Platform & Immune Monitoring of CAR/TCR Products.” Wednesday, September 21st at 2:30PM ET. adaptivebio.tech/df8

Congrats to Katie Lowe, recipient of our 2022 WISE Award! Katie's research aims to characterize the TCR diversity in lymphoid infiltrated synovial tissue (LIST) patients with rheumatoid arthritis. adaptivebio.tech/n2p For Research Use Only. Not for use in diagnostic procedures

The financing with OrbiMed will provide flexibility to invest in growth initiatives in both MRD and Immune Medicine businesses. Press release: adaptivebio.tech/mst

This #bloodcancerawareness month, SVP Susan Bobulsky discusses Adaptive’s “patient first” culture and recent efforts with @ACCCbuzz and @NCODAorg to share minimal residual disease (MRD) education with community doctors treating blood cancers. Blog post: adaptivebio.tech/x5y

Attending the @DPC_Summit next week? On Wednesday, September 7th at 11:20am ET, join Katie Boland, DVM, PhD for her presentation, “Turning large scale immune repertoire data into insights in infectious disease.” More info: adaptivebio.tech/di7

Join Adaptive’s Mia Barnes, Sr. Medical Science Liaison, at this year’s @DPC_Summit for a talk on, "T-cell immune response: vaccine development and COVID-19 variants.” Wednesday, September 7th at 12:20pm ET. Register here: adaptivebio.tech/di7

Thanks, @Nasdaq! We are so proud of our team and all participants who made this 10th anniversary of #Obliteride a success with raising funds to support lifesaving research.

Congrats to Claire Guinier, our Q2 2022 Young Investigator Award winner! Her research aims to understand the role of T cells in CAV, the leading cause of mortality following heart transplantation. adaptivebio.tech/inl For Research Use Only. Not for use in diagnostic procedures

Sr. Medical Director Allison Jacob discusses the recent @bloodcancerjnl survey by @bdermanmd and the shifting clinician attitudes on MRD-guided decision making in multiple myeloma. Read the blog: adaptivebio.tech/ag4

Congrats to Girija Goyal, PhD, winner of our 2022 WISE Award! Learn more about her research into the use of LN chips to replicate and study human immune response to infection & vaccination at adaptivebio.tech/ywf. For research Use Only. Not for use in diagnostic procedures.

#Obliteride is an inspiring event and we're so proud of Team Adaptive and all the participants who took part in the cause to raise funds for life-saving cancer research. A big shout-out to Adaptive’s @bryan_howie for biking 4K miles and Team Adaptive for logging over 9K miles!

The Sustainability @ Adaptive Employee Resource Group kicked off the first official harvest of the Adaptive rooftop garden a few weeks ago and made a donation to the @udistfoodbank! We're looking forward to the next harvest!

MRD Chief Commercial Officer Nitin Sood discusses being on the patient’s side of the cancer journey and the profound influence it has in shaping his career path. adaptivebio.tech/k9a

Happy National Intern Day! We’re delighted to work with all our amazing 2022 interns. Here are a few members of the cohort, who are joining us from locations and institutions across the country. #nationalinternday

.@clonoSEQ is the first and only MRD assay to receive Medicare coverage in DLBCL. Press release: adaptivebio.tech/gdp clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For important info. incl. sample types & test limitations: rb.gy/8tju9y

Immune Medicine has the power to transform how we detect and treat disease. Learn how Adaptive is harnessing the adaptive immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine. adaptivebio.tech/svt

We’re proud to be a sponsor of the 4th Cell Therapies and Immunotherapy Conference! Join Adaptive’s Amy Gilbert and Amritha Lewis as they discuss advancements in cell-based immunotherapies. More info: adaptivebio.tech/8f2 #SBE #CellTherapies22

If you have turned on the news recently, you may have heard of talk about antibodies, antigens and T cells. In this short primer, we break down the cast of characters in your adaptive immune system.